Literature DB >> 20570219

Osteopenia in Cftr-deltaF508 mice.

Josée Paradis1, Martina Wilke, Christina K Haston.   

Abstract

BACKGROUND: Mice with the cystic fibrosis transmembrane conductance regulator (Cftr) gene knocked out develop osteopenia. To determine whether this phenotype is present in cystic fibrosis mouse models with the DeltaF508 Cftr mutation we assessed the femora of adult FVB/N Cftr(tm1Eur) and C57BL/6 Cftr(tm1Kth) mice.
METHODS: Bone disease, relative to littermate controls, was measured using histology, densitometry and quantitative imaging.
RESULTS: C57BL/6 Cftr(tm1Kth) mice had shorter femurs and bones of lower volume due to thinner trabeculae, compared to wild type littermates. FVB/N Cftr(tm1Eur) mice also presented a lower bone volume which was due to significantly fewer trabeculae in this strain. Osteoblast and osteoclast numbers did not differ between CF and controls, for either of FVB/N Cftr(tm1Eur) or C57BL/6 Cftr(tm1Kth) mice. The bone architecture of FVB/N Cftr(tm1Eur) mice did not significantly differ from that of C57BL/6 Cftr(tm1Kth) mice.
CONCLUSIONS: An osteopenic bone disease is evident in adult DeltaF508-Cftr cystic fibrosis mouse models. Copyright 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570219     DOI: 10.1016/j.jcf.2010.05.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  5 in total

1.  Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.

Authors:  Mark Bazett; Lisa Honeyman; Anguel N Stefanov; Christopher E Pope; Lucas R Hoffman; Christina K Haston
Journal:  Mamm Genome       Date:  2015-02-27       Impact factor: 2.957

2.  Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice.

Authors:  Carole Le Henaff; Rafik Mansouri; Dominique Modrowski; Mylène Zarka; Valérie Geoffroy; Caroline Marty; Nadine Tarantino; Emmanuel Laplantine; Pierre J Marie
Journal:  J Biol Chem       Date:  2015-06-09       Impact factor: 5.157

3.  The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis.

Authors:  Melissa S Putman; Logan B Greenblatt; Michael Bruce; Taisha Joseph; Hang Lee; Gregory Sawicki; Ahmet Uluer; Leonard Sicilian; Isabel Neuringer; Catherine M Gordon; Mary L Bouxsein; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

4.  Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model.

Authors:  Mark Bazett; Marie-Eve Bergeron; Christina K Haston
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

5.  Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat.

Authors:  Michael S Stalvey; Viktoria Havasi; Katherine L Tuggle; Dezhi Wang; Susan Birket; Steve M Rowe; Eric J Sorscher
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.